Related Experiment Video
Updated: Dec 17, 2025

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy
Maximos Frountzas1, Panagiotis Karathanasis2, Gavriella Zoi Vrakopoulou2
11st Department of Propaedeutic Surgery, Medical School, "Hippocratio" General Hospital, University of Athens, 114 Vas. Sophias Av, 11527, Athens, Greece. froumax@hotmail.com.
Background:
Kounis syndrome (KS) has been described as an acute coronary syndrome (ACS) associated with an anaphylactic reaction. Several triggers have been identified and the diagnostic and treatment process can be challenging.
Case:
A 58-year-old, female patient diagnosed with breast cancer and no history of allergies had subcutaneous injection of patent blue V dye for sentinel lymph node biopsy (SLNB). Intraoperatively, she developed anaphylactic shock and was transferred to the intensive care unit (ICU). A few hours later, electrocardiographic alterations and elevation of blood troponin were observed. Emergency coronary angiography revealed no occlusive lesions in coronary vessels. Further investigation in the allergy department set the diagnosis of KS.
Conclusion:
There are just ten cases of perioperative KS in the literature so far and here we present the first one triggered by patent blue V dye for sentinel node biopsy.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Imaging Studies III: Computed Tomography
Cardiac Catheterization IV: Nursing Management
Nephrotic Syndrome I : Introduction
Imaging Studies I: Kidney, Ureter, and Bladder Studies

